Oncology

Latest News

Flatiron Health, DeepScribe Unveil Partnership to Provide Oncology-Specific Ambient AI

By Mary Caffrey

January 22nd 2025

DeepScribe's technology aims to free doctors to focus on the patient visit.

Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration

By Denise Tran, PharmD
Haesuk Park, PhD

January 20th 2025

The new guideline is the NCCN’s first patient resource on the topic of cancer genetics and hereditary cancer risk. | Image credit: Connect world - stock.adobe.com

NCCN Publishes Patient Guidance on Genetic Testing for Cancer Risk

By Rose McNulty

January 16th 2025

Patient receiving lung cancer screening results | Image Credit: Nattakorn - stock.adobe.com

Lung Cancer Screening Facilities Least Accessible to American Indian/Alaska Native Patients, Rural Communities

By Brooke McCormick

January 13th 2025

Child standing on scale | Image Credit: Protsenko Dmitriy - stock.adobe.com

Obesity at Cancer Diagnosis Linked to Worse Survival Outcomes in Pediatric Patients

By Brooke McCormick

January 13th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

June 14th 2012

Inefficiencies in Oncology Continue to Prove Costly

The Center for Health Value Innovation (CHVI) presented a webinar yesterday that touched on clinical pathways for oncology and how value-based approaches will help to improve health and financial outcomes.

June 5th 2012

ASCO: Cymbalta Tames Post-Chemo Pain

June 4th 2012

Cancer Treatments Grow More High-Tech: 'Smart Bomb' Drugs, Immune Boosters are Seeing Success

May 31st 2012

ASCO Advocates for New Payment Models That Reward Quality of Care

May 29th 2012

Insurers Forcing Patients to Pay More for Costly Specialty Drugs

May 25th 2012

Screening Finds Skin Cancer, But Does It Save Lives?

May 24th 2012

Value-Based Reimbursement in Oncology

J. Russell Hoverman, MD, PhD

Getting On Pathway?

May 24th 2012

The 2012 New York ASCO Checklist

May 24th 2012

Testing for ALK-Positive NSCLC

Keith Beagin

Signaling the Future of Personalized Medicine

May 24th 2012

Prostate Cancer

Jennifer Klemm, PhD Stanton R. Mehr

May 24th 2012

Long-Term Breast Cancer Patient Follow-Up Care

Anna Azvolinsky, PhD

Money Well Spent?

May 24th 2012

Myeloproliferative Disorders and Myelofibrosis

Marjorie P. Zimmerman, MS, BSPharm, RPh Stanton R. Mehr

May 24th 2012

BRCA1/2 Genetic Testing Found Cost-Effective in Current Era

Alice Goodman

SABCS Conference Coverage

May 24th 2012

Trends in the 2012 Eisai Oncology Digest: Patient Demographics and Cancer Treatment Goals

This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.

May 24th 2012

Literature Review

Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy

May 24th 2012

On the Horizon for Multiple Myeloma

Michael Marlan Mohundro, PharmD Brice Labruzzo Mohundro, PharmD

Availability of Newer Agents May Lower Healthcare Costs

May 24th 2012

Oncology Hit Hard by SGR Debacle

Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology

May 23rd 2012

First Cancer-Specific ACO Launches

May 23rd 2012

Forging a Pathway to Quality Cancer Care

Kim Farina, PhD

UPMC Oncologists: Pioneers in the Clinical Pathways Movement

May 23rd 2012

Is Provenge Angst a Symbol or Symptom of the Times?

Dawn G. Holcombe, MBA, FAMCPE, ACHE

May 23rd 2012

Chronic Myelogenous Leukemia

Jennifer Klemm, PhD Stanton R. Mehr

May 23rd 2012

Economic Benefits of BIS-Aided Assessment of Post-BC Lymphedema in the United States

Sara P. Bilir, MS Mitchell P. DeKoven, MHSA Juliet Munakata, MS

Use of bioimpedance spectroscopy to aid in post“breast cancer assessments for lymphedema can be cost saving for healthcare organizations in the United States.

May 22nd 2012

Docs Need Primer on Long-Term Effects of Chemotherapy

Many primary care physicians - and even some oncologists - are unaware of common long-term side effects of four widely used breast and colorectal cancer drugs, a national survey by the National Cancer Institute reveals.

May 18th 2012

Implementation of Cancer Clinical Care Pathways: A Successful Model of Collaboration Between Payers and Providers

Bruce A. Feinberg, DO James Lang, PharmD, MBA James Grzegorczyk, MS, RPh Donna Stark, RPh, MBA Thomas Rybarczyk, RN, BSN Thomas Leyden, MBA Joseph Cooper Thomas Ruane, MD Scott Milligan, PhD Philip Stella, MD Jeffrey A. Scott, MD

A statewide collaboration between payers and providers to create a cancer clinical care pathways program is successful.

May 18th 2012

Payer Coverage for Patients Enrolled Onto Clinical Trials: Making the Process Easy and Transparent for Everyone

Carol S. Palackdharry, MD, MS David L. Evans, MD Robert S. McDonough, MD Melissa E. Clarke, MD James D. Cross, MD Ira M. Klein, MD, MBA Lonny Reisman, MD

It is not just 1 physician who cares for a patient enrolled onto a clinical trial but rather a complex system of several physician teams, sometimes with very different opinions, who must work together for therapy to be successful and for the patient to have faith in his treating team.

May 18th 2012

Oncology Patient-Centered Medical Home

John D. Sprandio, MD, FACP

The oncology patient“centered medical home is a physician-driven, patient-focused value proposition that can make a difference for patients, oncologists, and the cost of healthcare.

May 18th 2012

ASCO '12 Abstract Dump: Cancer Stocks in Focus

May 16th 2012

Drug Makers Shifting Towards Targeted Cancer Drugs

May 16th 2012

Surya Singh, MD, Addresses Ways to Manage Oncology Spending in Specialty Pharmacy

Dr. Singh discusses CVS Caremark's strategies for managing oncology spending.

May 10th 2012

Visit Duration for Outpatient Physician Office Visits Among Patients With Cancer

Gery P. Guy Jr, PhD, MPH Lisa C. Richardson, MD, MPH

Higher use of performance-based payment mechanisms and capitated arrangements is associated with a decrease in the amount of time physicians spend with patients with cancer.

...

173 174 175 176 177 178 179 180 181 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions